http://rdf.ncbi.nlm.nih.gov/pubchem/patent/ES-2313002-T3
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5f7b665fb8f15d0e2b0911539d39f8a2 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4535 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-454 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-496 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-5377 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-404 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4045 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4535 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-454 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-496 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5377 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4045 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-404 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-04 |
| filingDate | 2004-05-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2009-03-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1c2d5a846f1410d16589800ad87b49c9 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_551cf4621b69233889d5e5e8316ef09f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c92da31969092a365b1fe2337e65caf1 |
| publicationDate | 2009-03-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | ES-2313002-T3 |
| titleOfInvention | USE OF SULFONAMIDE DERIVATIVES FOR THE MANUFACTURE OF A MEDICINAL PRODUCT FOR PROFILAXIS AND / OR TREATMENT OF FOOD INGESTION. |
| abstract | Use of at least one sulfonamide derivative of the general formula (I), (See formula) in which R 1 represents hydrogen, an optionally at least monosubstituted linear or branched alkyl radical, an optionally at least monosubstituted phenyl radical or an optionally benzyl radical at least monosubstituted, R 2 represents a moiety -NR 4 R 5 R 3 represents hydrogen or an optionally at least monosubstituted linear or branched alkyl radical, R 4 and R 5, the same or different, represent hydrogen or a linear C1-C4 alkyl radical or branched, or R 4 and R 5 together with the bridge nitrogen atom form a moiety selected from the group consisting of (See formula) in which R 7 represents hydrogen, a linear or branched C1-C4 alkyl radical or a benzyl radical, A represents an optionally at least monosubstituted mono- or polycyclic aromatic ring system, which may be linked through an optionally at least monosubstituted alkylene group, opken alkenylene nally at least monosubstituted or optionally at least monosubstituted alkynylene and / or may contain at least one heteroatom as a ring member in one or more of its rings, n represents 0, 1, 2, 3 or 4; optionally in the form of one of its stereoisomers, preferably enantiomers or diastereoisomers, its racemate or in the form of a mixture of at least two of its stereoisomers, preferably enantiomers or diastereoisomers, in any mixing ratio, or a corresponding physiologically acceptable salt or solvate correspondent. for the manufacture of a medicament for the prophylaxis and / or treatment of a food ingestion disorder. |
| priorityDate | 2003-05-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 218.